Boston Trust Walden Trims Qualys Stake Amid Sector Volatility

Boston Trust Walden Corp has decreased its exposure to Qualys, Inc. (QLYS), selling 93,512 shares during the first quarter of 2026. According to a recent SEC filing, the estimated value of the transaction was approximately $10.36 million, based on average quarterly pricing. The fund's total position value in the cloud-security provider dropped by $57.95 million quarter-over-quarter. This decline was driven by a combination of the partial divestment and broader share price depreciation. Despite the sale, Boston Trust Walden retains a substantial stake of 1,010,376 shares, valued at $88.76 million, although the holding has now fallen outside the fund's top five positions. Qualys continues to navigate a challenging environment for cybersecurity equities, with its share price retreating more than 45% from the high-water mark set in November. To counter competitive pressures and the rise of generative AI, the company launched its first AI agent for autonomous remediation and exploit validation in March. Financial performance remains steady, with 2025 revenues reaching $669.1 million, a 10% increase, and net income rising 14% to $222 million. Looking forward, management has provided a conservative revenue growth guidance of 7% to 8% for the full year 2026. Market participants are now focusing on the upcoming first-quarter earnings report scheduled for May 5, 2026, which will provide further clarity on the company's growth trajectory and the market adoption of its new AI-driven tools.